Evidence map›Paper›PMID 39974299›Full record

ArticleCureus2025

DeepSeek in Healthcare: Revealing Opportunities and Steering Challenges of a New Open-Source Artificial Intelligence Frontier.

Abdulrahman Temsah, Khalid Alhasan, Ibraheem Altamimi, Amr Jamal, Ayman Al-Eyadhy, Khalid H Malki, Mohamad-Hani Temsah

Abstract readEditorial
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdulrahman TemsahSoftware Engineering, Alfaisal University, Riyadh, SAU.
Khalid AlhasanPediatric Department, College of Medicine, King Saud University, Riyadh, SAU.
Ibraheem AltamimiEvidence-Based Research Chair, Family and Community Medicine, College of Medicine, King Saud University, Riyadh, SAU.
Amr JamalEvidence-Based Research Chair, Family and Community Medicine, College of Medicine, King Saud University, Riyadh, SAU.
Ayman Al-EyadhyPediatric Department, College of Medicine, King Saud University, Riyadh, SAU.
Khalid H MalkiResearch Chair of Voice, Swallowing, and Communication Disorders, Department of Otolaryngology-Head and Neck Surgery, College of Medicine, King Saud University, Riyadh, SAU.
Mohamad-Hani TemsahPediatric Department, College of Medicine, King Saud University, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative Artificial Intelligence (GAI) has driven several advancements in healthcare, with large language models (LLMs) such as OpenAI's ChatGPT, Google's Gemini, and Microsoft's Copilot demonstrating potential in clinical decision support, medical education, and research acceleration. However, their closed-source architecture, high computational costs, and limited adaptability to specialized medical contexts remained key barriers to universal adoption. Now, with the rise of DeepSeek's DeepThink (R1), an open-source LLM, gaining prominence since mid-January 2025, new opportunities and challenges emerge for healthcare integration and AI-driven research. Unlike proprietary models, DeepSeek fosters continuous learning by leveraging publicly available open-source datasets, possibly enhancing adaptability to the ever-evolving medical knowledge and scientific reasoning. Its transparent, community-driven approach may enable greater customization, regional specialization, and collaboration among data researchers and clinicians. Additionally, DeepSeek supports offline deployment, addressing some data privacy concerns. Despite these promising advantages, DeepSeek presents ethical and regulatory challenges. Users' data privacy worries have emerged, with concerns about user data retention policies and potential developer access to user-generated content without opt-out options. Additionally, when used in healthcare applications, its compliance with China's data-sharing regulations highlights the urgent need for clear international data privacy and governance. Furthermore, like other LLMs, DeepSeek may face limitations related to inherent biases, hallucinations, and output reliability, which warrants rigorous validation and human oversight before clinical application. This editorial explores DeepSeek's potential role in clinical workflows, medical education, and research while also highlighting its challenges related to security, accuracy, and responsible AI governance. With careful implementation, ethical considerations, and international collaboration, DeepSeek and similar LLMs could enhance healthcare innovation, providing cost-effective, scalable AI solutions while ensuring human expertise remains at the forefront of patient care.

Indexed as

ai hallucinations and bias in medicinedeepseek deepthink r1 open-source aiethical considerations in ai-driven healthcaregenerative artificial intelligence (gai) in healthcarehealthcare data privacy and ai compliancehipaa and gdpr ai compliancelarge language models (llms) in medicinemedical education and ai integrationoffline ai deployment for healthcareopen-source ai for medical research

Identifiers

PMID39974299
PMCPMC11836063

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.